TransEnterix, Inc. (NYSE: TRXC) today announced the Company has filed its response to the Food and Drug Administration’s (“FDA”) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE